Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Atrial fibrillation - Evidence
Supporting evidence

This section reviews the evidence for drugs used to control heart rate (for example beta-blockers and rate-limiting calcium-channel blockers [diltiazem and verapamil]).

This section does not review the evidence for drugs which control heart rhythm (sotalol, flecainide, or amiodarone) because these drugs are usually initiated under specialist advice in secondary care.

[Lip et al, 2002]

© NHS Institute for Innovation and Improvement